An intermediate phenotype in IDH related enchondromatosis spectrum.

Enchondromatosis IDH1 Metaphyseal enchondromatosis with D-2- hydroxyglutaric aciduria (MC-HGA) Skeletal dysplasia Whole exome sequencing

Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 01 09 2022
revised: 21 11 2022
accepted: 07 01 2023
pubmed: 18 1 2023
medline: 14 2 2023
entrez: 17 1 2023
Statut: ppublish

Résumé

Mosaic variants of IDH1 (isocitrate dehydrogenase-1) R132 and IDH2 (isocitrate dehydrogenase-2) R172 loci were detected in most of the bone cysts of Ollier and Maffucci series and in the blood and tissue samples of metaphyseal enchondromatosis with D-2-hydroxyglutaric aciduria (MC-HGA) patients. We aimed to report an intermediate phenotype comparing with the reported cases. The proband was a 9-year-old boy with widespread metaphyseal enchondromatosis involving metaphyses of long tubular bones, iliac bones and tubular bones of both hands and feet and sparing spine and flat and short bones. He underwent quad whole exome sequencing (index-both parents-healthy sibling). Sanger sequencing was performed for confirmation and segregation purposes. Heterozygous IDH1 R132H (c.395G > A) variant was detected in his blood via whole exome sequencing and Sanger analysis in mosaic state, 22% of the reads and Sanger signal. He had no D-2-hydroxyglutaric aciduria in urinary organic acid analysis. Our case is unique with the presence of IDH1 R132H variant in blood with metaphyseal enchondromatosis without D-2-hydroxyglutaric aciduria. It was a transitional phenotype. With his phenotype, we expand the IDH1/IDH2 related enchondromatosis phenotypes.

Identifiants

pubmed: 36649847
pii: S1769-7212(23)00003-4
doi: 10.1016/j.ejmg.2023.104697
pii:
doi:

Substances chimiques

Isocitrate Dehydrogenase EC 1.1.1.41

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104697

Informations de copyright

Copyright © 2023 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no conflicts of interest to declare.

Auteurs

Elif Yilmaz-Gulec (E)

Department of Medical Genetics, Health Sciences University, Kanuni Sultan Suleyman Research and Training Hospital, Istanbul, Turkey. Electronic address: elif.yilmazgulec@medeniyet.edu.tr.

Pauline Marzin (P)

Université de Paris Cité, Génétique clinique, INSERM UMR 1163, Institut Imagine, Hôpital Necker-Enfants Malades (AP-HP), Paris, France.

Céline Huber-Lequesne (C)

Université de Paris Cité, Génétique clinique, INSERM UMR 1163, Institut Imagine, Hôpital Necker-Enfants Malades (AP-HP), Paris, France.

Valérie Cormier-Daire (V)

Université de Paris Cité, Génétique clinique, INSERM UMR 1163, Institut Imagine, Hôpital Necker-Enfants Malades (AP-HP), Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH